Related Experiment Video
Updated: Jul 26, 2026

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
Inhibiting ACSL1-Related Ferroptosis Restrains Murine Coronavirus Infection
Huawei Xia1, Zeming Zhang1, Fuping You1
1Department of Systems Biomedicine, Institute of Systems Biomedicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing 100191, China.
Abstract:
Murine hepatitis virus strain A59 (MHV-A59) was shown to induce pyroptosis, apoptosis, and necroptosis of infected cells, especially in the murine macrophages. However, whether ferroptosis, a recently identified form of lytic cell death, was involved in the pathogenicity of MHV-A59 is unknown. We utilized murine macrophages and a C57BL/6 mice intranasal infection model to address this. In primary macrophages, the ferroptosis inhibitor inhibited viral propagation, inflammatory cytokines released, and cell syncytia formed after MHV-A59 infection. In the mouse model, we found that in vivo administration of liproxstatin-1 ameliorated lung inflammation and tissue injuries caused by MHV-A59 infection. To find how MHV-A59 infection influenced the expression of ferroptosis-related genes, we performed RNA-seq in primary macrophages and found that MHV-A59 infection upregulates the expression of the acyl-CoA synthetase long-chain family member 1 (ACSL1), a novel ferroptosis inducer. Using ferroptosis inhibitors and a TLR4 inhibitor, we showed that MHV-A59 resulted in the NF-kB-dependent, TLR4-independent ACSL1 upregulation. Accordingly, ACSL1 inhibitor Triacsin C suppressed MHV-A59-infection-induced syncytia formation and viral propagation in primary macrophages. Collectively, our study indicates that ferroptosis inhibition protects hosts from MHV-A59 infection. Targeting ferroptosis may serve as a potential treatment approach for dealing with hyper-inflammation induced by coronavirus infection.
Insights
Murine hepatitis virus-A59 (MHV-A59) infection induces ferroptosis, a cell death pathway. Inhibiting ferroptosis protects against MHV-A59-induced lung inflammation and viral spread, suggesting a new therapeutic target.
Area of Science:
- Virology
- Immunology
- Cell Biology
Background:
- Murine hepatitis virus strain A59 (MHV-A59) causes cell death, including pyroptosis, apoptosis, and necroptosis.
- The role of ferroptosis, a distinct form of lytic cell death, in MHV-A59 pathogenicity remained unexplored.
Purpose of the Study:
- To investigate the involvement of ferroptosis in MHV-A59 infection.
- To explore ferroptosis-related gene expression changes during MHV-A59 infection.
- To evaluate the therapeutic potential of targeting ferroptosis against MHV-A59.
Main Methods:
- Utilized primary murine macrophages and a C57BL/6 mice intranasal infection model.
- Administered ferroptosis inhibitors (e.g., liproxstatin-1, Triacsin C) and performed RNA-sequencing.
- Investigated the role of Toll-like receptor 4 (TLR4) and NF-kB signaling pathways.
Main Results:
- Ferroptosis inhibition reduced viral propagation, inflammatory cytokine release, and syncytia formation in vitro.
- In vivo liproxstatin-1 administration ameliorated lung inflammation and tissue injury in infected mice.
- MHV-A59 infection upregulated acyl-CoA synthetase long-chain family member 1 (ACSL1), a ferroptosis inducer, in a NF-kB-dependent, TLR4-independent manner.
- ACSL1 inhibition suppressed MHV-A59-induced syncytia formation and viral propagation.
Conclusions:
- Ferroptosis plays a significant role in MHV-A59 pathogenesis.
- Inhibition of ferroptosis offers a protective effect against MHV-A59 infection and associated hyper-inflammation.
- Targeting ferroptosis, particularly ACSL1, presents a promising therapeutic strategy for coronavirus infections.
More Related Videos
09:10siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
04:01Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly